| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01873001 | Healthy Volunteers | Drug: Pioglitazone HCl|Drug: Abiraterone acetate | Janssen Research & Development, LLC | Phase 1 | 2013-05-01 | 2014-04-16 |
| NCT00649012 | Healthy | Drug: Pioglitazone HCl Tablets 45 mg|Drug: Actos庐 Tablets 45 mg | Mylan Pharmaceuticals | Phase 1 | 2003-03-01 | 2008-03-31 |
| NCT00649558 | Healthy | Drug: Pioglitazone HCl Tablets 45 mg|Drug: Actos庐 Tablets 45 mg | Mylan Pharmaceuticals | Phase 1 | 2003-02-01 | 2008-03-31 |
| NCT00494559 | Diabetes Mellitus|Coronary Artery Stenosis | Drug: Pioglitazone|Drug: Placebo | Korea University Anam Hospital | Phase 4 | 2007-07-01 | 2016-02-24 |
| NCT01090752 | Diabetes|Hypertension | Drug: Pioglitazone|Drug: Metformin | University Hospital, Geneva|University of Lausanne Hospitals | Phase 4 | 2005-10-01 | 2010-03-24 |
| NCT03080480 | Chronic Granulomatous Disease | Drug: Pioglitazone | Children's Hospital of Fudan University | Phase 1|Phase 2 | 2017-04-01 | 2017-03-14 |
| NCT00671515 | Depressive Disorder, Major|Metabolic Syndrome X | Drug: Pioglitazone | Joseph Calabrese, MD|Takeda Pharmaceuticals North America, Inc.|University Hospitals Cleveland Medical Center | Phase 2 | 2008-04-01 | 2016-11-30 |
| NCT02697617 | Polycystic Kidney Disease | Drug: Pioglitazone|Drug: Placebo | Indiana University | Phase 2 | 2015-10-01 | 2016-10-13 |
| NCT01151670 | Brain Neoplasms, Malignant|Brain Neoplasms, Benign|Malignant Meningioma|Glioblastoma Multiforme|Anaplastic Astrocytoma | Drug: pioglitazone|Drug: Pioglitazone | Wake Forest University Health Sciences | Phase 1 | 2010-08-01 | 2017-01-17 |
| NCT02687425 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Drug: Pioglitazone|Drug: imatinib mesylate | Meng Li|Tongji Hospital | Phase 2 | 2016-02-01 | 2016-02-16 |
| NCT00719381 | Cystic Fibrosis | Drug: Pioglitazone | Paul Beringer|University of Southern California | Phase 1 | 2008-01-01 | 2012-06-13 |
| NCT01637935 | Diabetes|Bladder Cancer | Drug: Pioglitazone | Takeda|Kaiser Permanente|Department of Epidemiology at University of Pennsylvania | | 2004-07-01 | 2015-12-09 |
| NCT01352182 | Severe Sepsis|Septic Shock | Drug: Pioglitazone hydrochloride | Children's Hospital Medical Center, Cincinnati | Phase 1|Phase 2 | 2011-10-01 | 2017-01-05 |
| NCT00672919 | Diabetes Mellitus | Drug: Pioglitazone | Takeda | Phase 4 | 2003-11-01 | 2012-02-27 |
| NCT01931566 | Mild Cognitive Impairment Due to Alzheimer's Disease | Drug: Pioglitazone|Drug: Pioglitazone placebo | Takeda|Zinfandel Pharmaceuticals Inc. | Phase 3 | 2013-08-01 | 2017-01-31 |
| NCT00835120 | Metabolic Syndrome|Bipolar Depression|Insulin Resistance | Drug: Pioglitazone | University Hospitals Cleveland Medical Center|National Alliance for Research on Schizophrenia and Depression|Takeda Pharmaceuticals North America, Inc. | Phase 4 | 2009-03-01 | 2016-11-30 |
| NCT00845182 | Type 2 Diabetes|Healthy|Impaired Glucose Tolerance | Drug: Pioglitazone|Drug: Exenatide|Drug: Pioglitazone and Exenatide | The University of Texas Health Science Center at San Antonio | Phase 4 | 2007-06-01 | 2015-08-08 |
| NCT00220961 | Impaired Glucose Tolerance|Type 2 Diabetes | Drug: Pioglitazone|Drug: Placebo | The University of Texas Health Science Center at San Antonio|University of Texas|Takeda Pharmaceuticals North America, Inc. | Phase 3 | 2004-01-01 | 2016-06-29 |
| NCT02958956 | Diabetes Mellitus, Type 2, Cancer | Drug: Pioglitazone | Takeda | | 1997-01-01 | 2016-11-12 |
